We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+15.27%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$17.3B
AUM Growth
+$1.38B
Cap. Flow
-$440M
Cap. Flow %
-2.54%
Top 10 Hldgs %
32.07%
Holding
728
New
61
Increased
216
Reduced
343
Closed
55

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$85M
2
ABT icon
Abbott
ABT
+$53.8M
3
EXC icon
Exelon
EXC
+$46.6M
4
BSX icon
Boston Scientific
BSX
+$42.6M
5
ABBV icon
AbbVie
ABBV
+$32.4M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$80.5M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$54.5M
3
CRWD icon
CrowdStrike
CRWD
+$45.7M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$40.6M
5
MRK icon
Merck
MRK
+$39.3M

Sector Composition

Rank Sector Weight
1 Technology 36.26%
2 Healthcare 22.78%
3 Financials 10.33%
4 Consumer Discretionary 7.75%
5 Industrials 7.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMT icon
251
American Tower
AMT
$77.7B
$10.2M 0.06%
46,273
+183
+0.4% +$39.5K
GDDY icon
252
GoDaddy
GDDY
$12.8B
$10.2M 0.06%
56,461
-8,426
-13% -$1.51M
GMED icon
253
Globus Medical
GMED
$10.6B
$10.1M 0.06%
171,838
+22,783
+15% +$1.47M
COIN icon
254
Coinbase
COIN
$44.1B
$9.95M 0.06%
28,396
+6,868
+32% +$1.61M
JBL icon
255
Jabil
JBL
$32.6B
$9.89M 0.06%
+45,362
New +$7.35M
GLW icon
256
Corning
GLW
$123B
$9.68M 0.06%
183,990
-72,704
-28% -$3.4M
COR icon
257
Cencora
COR
$60.5B
$9.32M 0.05%
31,095
+23,808
+327% +$6.86M
LEGN icon
258
Legend Biotech
LEGN
$3.73B
$9.29M 0.05%
261,815
+39,983
+18% +$1.3M
VRSN icon
259
VeriSign
VRSN
$24.8B
$9.25M 0.05%
32,025
+23,470
+274% +$6.36M
WPC icon
260
W.P. Carey
WPC
$17B
$9.2M 0.05%
147,549
-89,326
-38% -$5.5M
HWM icon
261
Howmet Aerospace
HWM
$115B
$9.01M 0.05%
48,427
-2,892
-6% -$445K
ITW icon
262
Illinois Tool Works
ITW
$81.9B
$8.95M 0.05%
36,187
-3,856
-10% -$932K
GH icon
263
Guardant Health
GH
$19.3B
$8.87M 0.05%
170,522
-2,352
-1% -$105K
TERN
264
DELISTED
Terns Pharmaceuticals
TERN
$8.83M 0.05%
2,368,235
+214,266
+10% +$669K
BMI icon
265
Badger Meter
BMI
$3.71B
$8.81M 0.05%
35,964
-264
-0.7% -$59.8K
DOV icon
266
Dover
DOV
$27.7B
$8.68M 0.05%
47,387
-7,005
-13% -$1.22M
FUTU icon
267
Futu Holdings
FUTU
$14.6B
$8.66M 0.05%
70,057
-157,335
-69% -$16.1M
CIB icon
268
Grupo Cibest SA
CIB
$20.9B
$8.62M 0.05%
+186,598
New +$7.76M
TEAM icon
269
Atlassian
TEAM
$24.3B
$8.53M 0.05%
42,018
+30,522
+266% +$6.36M
AZO icon
270
AutoZone
AZO
$50.2B
$8.4M 0.05%
2,262
+78
+4% +$288K
ELVN icon
271
Enliven Therapeutics
ELVN
$3.77B
$8.36M 0.05%
+416,650
New +$7.89M
ZLAB icon
272
Zai Lab
ZLAB
$2.1B
$8.35M 0.05%
238,897
-2,044
-0.8% -$67.2K
KDP icon
273
Keurig Dr Pepper
KDP
$41B
$8.27M 0.05%
250,278
+119,723
+92% +$4.05M
NU icon
274
Nu Holdings
NU
$70.2B
$8.26M 0.05%
+522,000
New +$6.25M
NEM icon
275
Newmont
NEM
$98.5B
$8.16M 0.05%
140,040
+9,692
+7% +$517K

Similar funds

Candriam SCA's Q2 2025 Portfolio in Review

As of Q2 2025, Candriam SCA held 728 positions worth $17.3B, up 8.6% from $16B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Candriam SCA's Q2 2025 filing shows 61 new, 216 increased, 343 reduced and 55 closed positions. Its largest new stake was Tapestry: 260,834 shares worth $22.9M. The largest sale was Tesla, an estimated $80.5M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q2 2025 buy was Tapestry: 260,834 shares worth $22.9M.
  • Candriam SCA added most to Broadcom in Q2 2025, an estimated $85M increase.
  • Candriam SCA's biggest Q2 2025 reduction was Tesla, cutting an estimated $80.5M.
  • Candriam SCA fully exited Banco Macro in Q2 2025, selling an estimated $17.6M.
  • Candriam SCA's ten largest holdings make up 32% of its $17.3B portfolio in Q2 2025.
  • Candriam SCA opened 61 new positions and closed 55 in Q2 2025.
  • Candriam SCA's portfolio value rose 8.6% quarter-over-quarter to $17.3B.

Based on Candriam SCA's 13F filing for Q2 2025, filed 8 Aug 2025.